APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cisplatin Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cisplatin Injection Market Outlook and Growth Opportunities 2026

20 December 2025198 pages

Choose your research edition.

Industry ResearchCisplatin Injection Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cisplatin Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Cisplatin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cisplatin Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Cisplatin Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cisplatin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cisplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cisplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cisplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cisplatin Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cisplatin Injection market include Cipla, Hospira(Pfizer), Taj Pharmaceuticals, Fresenius Kabi, Lingnan Pharmacy, Hansoh Pharma, Jinzhou Jiutai Pharmaceutical, Nanjing Pharmaceutical Factory and Qilu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cisplatin Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cisplatin Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cisplatin Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cisplatin Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Cisplatin Injection Segment by Company

Cipla

Hospira(Pfizer)

Taj Pharmaceuticals

Fresenius Kabi

Lingnan Pharmacy

Hansoh Pharma

Jinzhou Jiutai Pharmaceutical

Nanjing Pharmaceutical Factory

Qilu Pharmaceutical

Luoxin

Teva

Bievalley

Yunnan Phytopharmaceutical

Cisplatin Injection Segment by Type

50ml

100ml

200ml

Cisplatin Injection Segment by Application

NSCLC

Testicular Cancer

Ovarian Cancer

Other

Cisplatin Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Cisplatin Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cisplatin Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cisplatin Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Cisplatin Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cisplatin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cisplatin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cisplatin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cisplatin Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cisplatin Injection industry.

Chapter 3: Detailed analysis of Cisplatin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cisplatin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cisplatin Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cisplatin Injection Industry Trends Table 2. Cisplatin Injection Industry Drivers Table 3. Cisplatin Injection Industry Opportunities and Challenges Table 4. Cisplatin Injection Industry Restraints Table 5. Global Cisplatin Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cisplatin Injection Revenue Share by Company (2021-2026) Table 7. Global Cisplatin Injection Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Cisplatin Injection Sales Volume Share by Company (2021-2026) Table 9. Global Cisplatin Injection Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Cisplatin Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cisplatin Injection Key Company Manufacturing Base & Headquarters Table 12. Global Cisplatin Injection Company, Product Type & Application Table 13. Global Cisplatin Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cisplatin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50ml Table 18. Significant Companies of 100ml Table 19. Significant Companies of 200ml Table 20. Global Cisplatin Injection Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Cisplatin Injection Sales Volume by Type (2021-2026) & (Tons) Table 22. Global Cisplatin Injection Sales Volume by Type (2027-2032) & (Tons) Table 23. Global Cisplatin Injection Sales Volume Share by Type (2021-2026) Table 24. Global Cisplatin Injection Sales Volume Share by Type (2027-2032) Table 25. Global Cisplatin Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cisplatin Injection Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Cisplatin Injection Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Cisplatin Injection Sales Value Share by Type (2021-2026) Table 29. Global Cisplatin Injection Sales Value Share by Type (2027-2032) Table 30. Significant Companies of NSCLC Table 31. Significant Companies of Testicular Cancer Table 32. Significant Companies of Ovarian Cancer Table 33. Significant Companies of Other Table 34. Global Cisplatin Injection Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 35. Global Cisplatin Injection Sales Volume by Application (2021-2026) & (Tons) Table 36. Global Cisplatin Injection Sales Volume by Application (2027-2032) & (Tons) Table 37. Global Cisplatin Injection Sales Volume Share by Application (2021-2026) Table 38. Global Cisplatin Injection Sales Volume Share by Application (2027-2032) Table 39. Global Cisplatin Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Cisplatin Injection Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Cisplatin Injection Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Cisplatin Injection Sales Value Share by Application (2021-2026) Table 43. Global Cisplatin Injection Sales Value Share by Application (2027-2032) Table 44. Global Cisplatin Injection Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 45. Global Cisplatin Injection Sales by Region (2021-2026) & (Tons) Table 46. Global Cisplatin Injection Sales Market Share by Region (2021-2026) Table 47. Global Cisplatin Injection Sales by Region (2027-2032) & (Tons) Table 48. Global Cisplatin Injection Sales Market Share by Region (2027-2032) Table 49. Global Cisplatin Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Cisplatin Injection Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Cisplatin Injection Sales Value Share by Region (2021-2026) Table 52. Global Cisplatin Injection Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Cisplatin Injection Sales Value Share by Region (2027-2032) Table 54. Global Cisplatin Injection Market Average Price (US$/Kg) by Region (2021-2026) Table 55. Global Cisplatin Injection Market Average Price (US$/Kg) by Region (2027-2032) Table 56. Global Cisplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 57. Global Cisplatin Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Cisplatin Injection Sales by Country (2021-2026) & (Tons) Table 59. Global Cisplatin Injection Sales Market Share by Country (2021-2026) Table 60. Global Cisplatin Injection Sales by Country (2027-2032) & (Tons) Table 61. Global Cisplatin Injection Sales Market Share by Country (2027-2032) Table 62. Global Cisplatin Injection Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Cisplatin Injection Sales Value Market Share by Country (2021-2026) Table 64. Global Cisplatin Injection Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Cisplatin Injection Sales Value Market Share by Country (2027-2032) Table 66. Cipla Company Information Table 67. Cipla Business Overview Table 68. Cipla Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 69. Cipla Cisplatin Injection Product Portfolio Table 70. Cipla Recent Development Table 71. Hospira(Pfizer) Company Information Table 72. Hospira(Pfizer) Business Overview Table 73. Hospira(Pfizer) Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Hospira(Pfizer) Cisplatin Injection Product Portfolio Table 75. Hospira(Pfizer) Recent Development Table 76. Taj Pharmaceuticals Company Information Table 77. Taj Pharmaceuticals Business Overview Table 78. Taj Pharmaceuticals Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Taj Pharmaceuticals Cisplatin Injection Product Portfolio Table 80. Taj Pharmaceuticals Recent Development Table 81. Fresenius Kabi Company Information Table 82. Fresenius Kabi Business Overview Table 83. Fresenius Kabi Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Fresenius Kabi Cisplatin Injection Product Portfolio Table 85. Fresenius Kabi Recent Development Table 86. Lingnan Pharmacy Company Information Table 87. Lingnan Pharmacy Business Overview Table 88. Lingnan Pharmacy Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Lingnan Pharmacy Cisplatin Injection Product Portfolio Table 90. Lingnan Pharmacy Recent Development Table 91. Hansoh Pharma Company Information Table 92. Hansoh Pharma Business Overview Table 93. Hansoh Pharma Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Hansoh Pharma Cisplatin Injection Product Portfolio Table 95. Hansoh Pharma Recent Development Table 96. Jinzhou Jiutai Pharmaceutical Company Information Table 97. Jinzhou Jiutai Pharmaceutical Business Overview Table 98. Jinzhou Jiutai Pharmaceutical Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. Jinzhou Jiutai Pharmaceutical Cisplatin Injection Product Portfolio Table 100. Jinzhou Jiutai Pharmaceutical Recent Development Table 101. Nanjing Pharmaceutical Factory Company Information Table 102. Nanjing Pharmaceutical Factory Business Overview Table 103. Nanjing Pharmaceutical Factory Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. Nanjing Pharmaceutical Factory Cisplatin Injection Product Portfolio Table 105. Nanjing Pharmaceutical Factory Recent Development Table 106. Qilu Pharmaceutical Company Information Table 107. Qilu Pharmaceutical Business Overview Table 108. Qilu Pharmaceutical Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. Qilu Pharmaceutical Cisplatin Injection Product Portfolio Table 110. Qilu Pharmaceutical Recent Development Table 111. Luoxin Company Information Table 112. Luoxin Business Overview Table 113. Luoxin Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 114. Luoxin Cisplatin Injection Product Portfolio Table 115. Luoxin Recent Development Table 116. Teva Company Information Table 117. Teva Business Overview Table 118. Teva Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 119. Teva Cisplatin Injection Product Portfolio Table 120. Teva Recent Development Table 121. Bievalley Company Information Table 122. Bievalley Business Overview Table 123. Bievalley Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 124. Bievalley Cisplatin Injection Product Portfolio Table 125. Bievalley Recent Development Table 126. Yunnan Phytopharmaceutical Company Information Table 127. Yunnan Phytopharmaceutical Business Overview Table 128. Yunnan Phytopharmaceutical Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 129. Yunnan Phytopharmaceutical Cisplatin Injection Product Portfolio Table 130. Yunnan Phytopharmaceutical Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Cisplatin Injection Distributors List Table 134. Cisplatin Injection Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Cisplatin Injection Product Image Figure 2. Global Cisplatin Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cisplatin Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cisplatin Injection Sales (2021-2032) & (Tons) Figure 5. Global Cisplatin Injection Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Cisplatin Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50ml Image Figure 10. 100ml Image Figure 11. 200ml Image Figure 12. Global Cisplatin Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Cisplatin Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Cisplatin Injection Sales Volume Share by Type (2021-2032) Figure 15. Global Cisplatin Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Cisplatin Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Cisplatin Injection Sales Value Share by Type (2021-2032) Figure 18. NSCLC Image Figure 19. Testicular Cancer Image Figure 20. Ovarian Cancer Image Figure 21. Other Image Figure 22. Global Cisplatin Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Cisplatin Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Cisplatin Injection Sales Volume Share by Application (2021-2032) Figure 25. Global Cisplatin Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Cisplatin Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Cisplatin Injection Sales Value Share by Application (2021-2032) Figure 28. Global Cisplatin Injection Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 29. Global Cisplatin Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Cisplatin Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Cisplatin Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Cisplatin Injection Sales Value (2021-2032) & (US$ Million) Figure 33. North America Cisplatin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Cisplatin Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Cisplatin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Cisplatin Injection Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Cisplatin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Cisplatin Injection Sales Value (2021-2032) & (US$ Million) Figure 39. South America Cisplatin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Cisplatin Injection Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Cisplatin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Cisplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Cisplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Cisplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Cisplatin Injection Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Cisplatin Injection Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 50ml
  • 100ml
  • 200ml
Applications
  • NSCLC
  • Testicular Cancer
  • Ovarian Cancer
  • Other
Companies covered
  • Cipla
  • Hospira(Pfizer)
  • Taj Pharmaceuticals
  • Fresenius Kabi
  • Lingnan Pharmacy
  • Hansoh Pharma
  • Jinzhou Jiutai Pharmaceutical
  • Nanjing Pharmaceutical Factory
  • Qilu Pharmaceutical
  • Luoxin
  • Teva
  • Bievalley
  • Yunnan Phytopharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cisplatin Injection Sales Value (2021-2032)
  4. 1.2.2 Global Cisplatin Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Cisplatin Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cisplatin Injection Market Dynamics
  1. 2.1 Cisplatin Injection Industry Trends
  2. 2.2 Cisplatin Injection Industry Drivers
  3. 2.3 Cisplatin Injection Industry Opportunities and Challenges
  4. 2.4 Cisplatin Injection Industry Restraints
3 Cisplatin Injection Market by Company
  1. 3.1 Global Cisplatin Injection Company Revenue Ranking in 2025
  2. 3.2 Global Cisplatin Injection Revenue by Company (2021-2026)
  3. 3.3 Global Cisplatin Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Cisplatin Injection Average Price by Company (2021-2026)
  5. 3.5 Global Cisplatin Injection Company Ranking (2024-2026)
  6. 3.6 Global Cisplatin Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Cisplatin Injection Company Product Type and Application
  8. 3.8 Global Cisplatin Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cisplatin Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cisplatin Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cisplatin Injection Market by Type
  1. 4.1 Cisplatin Injection Type Introduction
  2. 4.1.1 50ml
  3. 4.1.2 100ml
  4. 4.1.3 200ml
  5. 4.2 Global Cisplatin Injection Sales Volume by Type
  6. 4.2.1 Global Cisplatin Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Cisplatin Injection Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Cisplatin Injection Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Cisplatin Injection Sales Value by Type
  10. 4.3.1 Global Cisplatin Injection Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Cisplatin Injection Sales Value by Type (2021-2032)
  12. 4.3.3 Global Cisplatin Injection Sales Value Share by Type (2021-2032)
5 Cisplatin Injection Market by Application
  1. 5.1 Cisplatin Injection Application Introduction
  2. 5.1.1 NSCLC
  3. 5.1.2 Testicular Cancer
  4. 5.1.3 Ovarian Cancer
  5. 5.1.4 Other
  6. 5.2 Global Cisplatin Injection Sales Volume by Application
  7. 5.2.1 Global Cisplatin Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cisplatin Injection Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Cisplatin Injection Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Cisplatin Injection Sales Value by Application
  11. 5.3.1 Global Cisplatin Injection Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Cisplatin Injection Sales Value by Application (2021-2032)
  13. 5.3.3 Global Cisplatin Injection Sales Value Share by Application (2021-2032)
6 Cisplatin Injection Regional Sales and Value Analysis
  1. 6.1 Global Cisplatin Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cisplatin Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Cisplatin Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Cisplatin Injection Sales by Region (2027-2032)
  5. 6.3 Global Cisplatin Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cisplatin Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cisplatin Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cisplatin Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Cisplatin Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cisplatin Injection Sales Value (2021-2032)
  12. 6.6.2 North America Cisplatin Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cisplatin Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Cisplatin Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cisplatin Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cisplatin Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cisplatin Injection Sales Value (2021-2032)
  21. 6.9.2 South America Cisplatin Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cisplatin Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cisplatin Injection Sales Value Share by Country, 2025 VS 2032
7 Cisplatin Injection Country-level Sales and Value Analysis
  1. 7.1 Global Cisplatin Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cisplatin Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cisplatin Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Cisplatin Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Cisplatin Injection Sales by Country (2027-2032)
  6. 7.4 Global Cisplatin Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cisplatin Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cisplatin Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cisplatin Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cisplatin Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cisplatin Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cisplatin Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cisplatin Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cisplatin Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cisplatin Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cisplatin Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cisplatin Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cisplatin Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cisplatin Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cisplatin Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cisplatin Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cisplatin Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cisplatin Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cisplatin Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cisplatin Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cisplatin Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cisplatin Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cisplatin Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cisplatin Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cisplatin Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cisplatin Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cisplatin Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cisplatin Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cisplatin Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cisplatin Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cisplatin Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cisplatin Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cisplatin Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cipla
  2. 8.1.1 Cipla Company Information
  3. 8.1.2 Cipla Business Overview
  4. 8.1.3 Cipla Cisplatin Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cipla Cisplatin Injection Product Portfolio
  6. 8.1.5 Cipla Recent Developments
  7. 8.2 Hospira(Pfizer)
  8. 8.2.1 Hospira(Pfizer) Company Information
  9. 8.2.2 Hospira(Pfizer) Business Overview
  10. 8.2.3 Hospira(Pfizer) Cisplatin Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hospira(Pfizer) Cisplatin Injection Product Portfolio
  12. 8.2.5 Hospira(Pfizer) Recent Developments
  13. 8.3 Taj Pharmaceuticals
  14. 8.3.1 Taj Pharmaceuticals Company Information
  15. 8.3.2 Taj Pharmaceuticals Business Overview
  16. 8.3.3 Taj Pharmaceuticals Cisplatin Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Taj Pharmaceuticals Cisplatin Injection Product Portfolio
  18. 8.3.5 Taj Pharmaceuticals Recent Developments
  19. 8.4 Fresenius Kabi
  20. 8.4.1 Fresenius Kabi Company Information
  21. 8.4.2 Fresenius Kabi Business Overview
  22. 8.4.3 Fresenius Kabi Cisplatin Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius Kabi Cisplatin Injection Product Portfolio
  24. 8.4.5 Fresenius Kabi Recent Developments
  25. 8.5 Lingnan Pharmacy
  26. 8.5.1 Lingnan Pharmacy Company Information
  27. 8.5.2 Lingnan Pharmacy Business Overview
  28. 8.5.3 Lingnan Pharmacy Cisplatin Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lingnan Pharmacy Cisplatin Injection Product Portfolio
  30. 8.5.5 Lingnan Pharmacy Recent Developments
  31. 8.6 Hansoh Pharma
  32. 8.6.1 Hansoh Pharma Company Information
  33. 8.6.2 Hansoh Pharma Business Overview
  34. 8.6.3 Hansoh Pharma Cisplatin Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hansoh Pharma Cisplatin Injection Product Portfolio
  36. 8.6.5 Hansoh Pharma Recent Developments
  37. 8.7 Jinzhou Jiutai Pharmaceutical
  38. 8.7.1 Jinzhou Jiutai Pharmaceutical Company Information
  39. 8.7.2 Jinzhou Jiutai Pharmaceutical Business Overview
  40. 8.7.3 Jinzhou Jiutai Pharmaceutical Cisplatin Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jinzhou Jiutai Pharmaceutical Cisplatin Injection Product Portfolio
  42. 8.7.5 Jinzhou Jiutai Pharmaceutical Recent Developments
  43. 8.8 Nanjing Pharmaceutical Factory
  44. 8.8.1 Nanjing Pharmaceutical Factory Company Information
  45. 8.8.2 Nanjing Pharmaceutical Factory Business Overview
  46. 8.8.3 Nanjing Pharmaceutical Factory Cisplatin Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nanjing Pharmaceutical Factory Cisplatin Injection Product Portfolio
  48. 8.8.5 Nanjing Pharmaceutical Factory Recent Developments
  49. 8.9 Qilu Pharmaceutical
  50. 8.9.1 Qilu Pharmaceutical Company Information
  51. 8.9.2 Qilu Pharmaceutical Business Overview
  52. 8.9.3 Qilu Pharmaceutical Cisplatin Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Qilu Pharmaceutical Cisplatin Injection Product Portfolio
  54. 8.9.5 Qilu Pharmaceutical Recent Developments
  55. 8.10 Luoxin
  56. 8.10.1 Luoxin Company Information
  57. 8.10.2 Luoxin Business Overview
  58. 8.10.3 Luoxin Cisplatin Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Luoxin Cisplatin Injection Product Portfolio
  60. 8.10.5 Luoxin Recent Developments
  61. 8.11 Teva
  62. 8.11.1 Teva Company Information
  63. 8.11.2 Teva Business Overview
  64. 8.11.3 Teva Cisplatin Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Teva Cisplatin Injection Product Portfolio
  66. 8.11.5 Teva Recent Developments
  67. 8.12 Bievalley
  68. 8.12.1 Bievalley Company Information
  69. 8.12.2 Bievalley Business Overview
  70. 8.12.3 Bievalley Cisplatin Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Bievalley Cisplatin Injection Product Portfolio
  72. 8.12.5 Bievalley Recent Developments
  73. 8.13 Yunnan Phytopharmaceutical
  74. 8.13.1 Yunnan Phytopharmaceutical Company Information
  75. 8.13.2 Yunnan Phytopharmaceutical Business Overview
  76. 8.13.3 Yunnan Phytopharmaceutical Cisplatin Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Yunnan Phytopharmaceutical Cisplatin Injection Product Portfolio
  78. 8.13.5 Yunnan Phytopharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cisplatin Injection Value Chain Analysis
  2. 9.1.1 Cisplatin Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cisplatin Injection Sales Mode & Process
  6. 9.2 Cisplatin Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cisplatin Injection Distributors
  9. 9.2.3 Cisplatin Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst